These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25636929)

  • 1. Treatment outcome of patients with isoniazid mono-resistant tuberculosis.
    Chien JY; Chen YT; Wu SG; Lee JJ; Wang JY; Yu CJ
    Clin Microbiol Infect; 2015 Jan; 21(1):59-68. PubMed ID: 25636929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis.
    Chierakul N; Saengthongpinij V; Foongladda S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S86-90. PubMed ID: 24772584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.
    Thai PVK; Ha DTM; Hanh NT; Day J; Dunstan S; Nhu NTQ; Kiet VS; Lan NH; Dung NH; Lan NTN; Thuong NT; Lan NN; Liễu PTT; Hồng NT; Điệp ĐC; Thanh NTK; Hội NV; Nghĩa NV; Đại TN; Minh HQ; Thơm NV; Farrar J; Caws M
    BMC Infect Dis; 2018 Mar; 18(1):112. PubMed ID: 29510687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
    Farah MG; Tverdal A; Steen TW; Heldal E; Brantsaeter AB; Bjune G
    BMC Public Health; 2005 Feb; 5():14. PubMed ID: 15698472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.
    Báez-Saldaña R; Delgado-Sánchez G; García-García L; Cruz-Hervert LP; Montesinos-Castillo M; Ferreyra-Reyes L; Bobadilla-Del-Valle M; Canizales-Quintero S; Ferreira-Guerrero E; Téllez-Vázquez N; Montero-Campos R; Yanes-Lane M; Mongua-Rodriguez N; Martínez-Gamboa RA; Sifuentes-Osornio J; Ponce-de-León A
    PLoS One; 2016; 11(12):e0168955. PubMed ID: 28030600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of tuberculosis: epidemiology, resistance and monitoring.
    Bang D
    Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.
    Villegas L; Otero L; Sterling TR; Huaman MA; Van der Stuyft P; Gotuzzo E; Seas C
    PLoS One; 2016; 11(4):e0152933. PubMed ID: 27045684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.
    Nagaraja C; Shashibhushan BL; Asif M; Manjunath PH; Sagar C
    Indian J Chest Dis Allied Sci; 2012; 54(1):23-6. PubMed ID: 22779119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
    Edwards BD; Edwards J; Cooper R; Kunimoto D; Somayaji R; Fisher D
    PLoS One; 2020; 15(3):e0229691. PubMed ID: 32155169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance of Mycobacterium tuberculosis complex in central Taiwan.
    Liu CE; Chen C-; Hsiao JH; Young TG; Tsay RW; Fung CP
    J Microbiol Immunol Infect; 2004 Oct; 37(5):295-300. PubMed ID: 15497011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
    Schechter MC; Bizune D; Kagei M; Machaidze M; Holland DP; Oladele A; Wang YF; Rebolledo PA; Ray SM; Kempker RR
    Clin Infect Dis; 2017 Nov; 65(11):1862-1871. PubMed ID: 29020173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
    Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
    Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
    Fujiwara PI; Cook SV; Rutherford CM; Crawford JT; Glickman SE; Kreiswirth BN; Sachdev PS; Osahan SS; Ebrahimzadeh A; Frieden TR
    Arch Intern Med; 1997 Mar; 157(5):531-6. PubMed ID: 9066457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis.
    Lee H; Jeong BH; Park HY; Jeon K; Huh HJ; Lee NY; Koh WJ
    Antimicrob Agents Chemother; 2016 Jan; 60(1):471-7. PubMed ID: 26525801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.